Results 161 to 170 of about 768,553 (208)

Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention.

Vaccine, 2019
OBJECTIVE To assess secondary, parent-reported outcomes from a randomized controlled trial (RCT) of a provider communication intervention aimed at improving adolescent HPV vaccination.
A. Dempsey, J. Pyrzanowski, E. Campagna, S. Lockhart, S. O'Leary   +4 more
semanticscholar   +1 more source

Global HPV vaccination

BMJ, 2011
Most deaths from cervical cancer occur in countries without the resources to screen, treat, or vaccinate against the disease.
openaire   +2 more sources

Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.

Vaccine, 2019
BACKGROUND Human papillomavirus (HPV) vaccine has been recommended in the United States since 2006 for routine vaccination of girls at age 11-12 years and through age 26 years for women not previously vaccinated.
L. Markowitz, A. Naleway, Rayleen M. Lewis, B. Crane, T. Querec, S. Weinmann, M. Steinau, E. Unger   +7 more
semanticscholar   +1 more source

Immunobiology of HPV and HPV vaccines

Gynecologic Oncology, 2008
Genital human papillomavirus (HPV) infection with both low- and high-risk types is common, but most infections resolve as a result of a cell-mediated immune response. Failure to induce an effective immune response is related to inefficient activation of innate immunity and ineffective priming of the adaptive immune response; this defective immune ...
openaire   +2 more sources

HPV Vaccine: Updates and Highlights

Acta Cytologica, 2019
HPV is the most common sexually transmitted biological agent and is the cause of many conditions in men and women, including precancer lesions and cancer.
Cristina Mendes de Oliveira, J. Fregnani, L. Villa   +2 more
semanticscholar   +1 more source

Factors influencing intention to obtain the HPV vaccine and acceptability of 2-, 4- and 9-valent HPV vaccines: A study of undergraduate female health sciences students in Fujian, China.

Vaccine, 2019
BACKGROUND Little research has been conducted on the intention to obtain HPV vaccine now that the vaccine is approved for use in China. Acceptance of the three HPV vaccines, which differ in valency and price, has never been investigated.
Yulan Lin, Zheng Lin, F. He, Zhijian Hu, G. Zimet, Haridah Alias, L. Wong   +6 more
semanticscholar   +1 more source

Mandatory HPV Vaccination

JAMA, 2012
Melissa B, Gilkey, Noel T, Brewer
  +7 more sources

Perceptions of politicization and HPV vaccine policy support.

Vaccine, 2019
BACKGROUND Since its FDA approval in 2006, the Human papillomavirus (HPV) vaccine has been politically-charged, given its association with sexual health among young women and its history of controversial, and largely unsuccessful, legislative mandates ...
Loren Saulsberry, E. Fowler, Rebekah H. Nagler, Sarah E. Gollust   +3 more
semanticscholar   +1 more source

Age for HPV vaccination

Vaccine, 2008
HPV vaccination of pre-pubescent girls will be effective for many girls. Vaccinating girls and women older than 12 years of age may accelerate the reduction in cervical cancer rates. Currently HPV vaccines are effective for at least 5 years in the prevention of HPV 16 and 18 associated precancerous lesions however the duration of vaccine protection is ...
Diane M, Harper, Jorma, Paavonen
openaire   +2 more sources

HPV Vaccine

JAMA, 2007
WILLIAM E. GOLDEN, ROBERT H. HOPKINS
  +5 more sources